Sign up
Pharma Capital

Peter Murray

President, Proactive Investors Canada

Peter brings a strong business journalism background to Proactive Investors, having co-managed Nikkei’s English financial news desk in Tokyo for several years. While in Japan he also ran his own consulting firm with major European investment banks as clients. His career to date spans the fields of journalism, equities research, and small-cap advisory/corporate finance.

1523606045_PM.JPG

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.